Importantly, the combination of cGAMP and the usage of the cholesterol-depleting agent methyl-β-cyclodextrin (MβCD) greatly enhances cellular responses to STING signaling and reduces tumor growth in a murine carcinoma model. Here, STING1 is linked to neoplasm.